References
1. Schleimer RP, Lichtenstein LM, Gillespie E. Inhibition of basophil
histamine release by anti-inflammatory steroids. Nature.1981;292(5822):454-455.
2. Schleimer RP, Schulman ES, MacGlashan DW, Jr., et al. Effects of
dexamethasone on mediator release from human lung fragments and purified
human lung mast cells. The Journal of clinical investigation.1983;71(6):1830-1835.
3. Schleimer RP, Rutledge BK. Cultured human vascular endothelial cells
acquire adhesiveness for neutrophils after stimulation with interleukin
1, endotoxin, and tumor-promoting phorbol diesters. J Immunol.1986;136(2):649-654.
4. Schleimer RP, Sterbinsky SA, Kaiser J, et al. IL-4 induces adherence
of human eosinophils and basophils but not neutrophils to endothelium.
Association with expression of VCAM-1. J Immunol.1992;148(4):1086-1092.
5. Ebisawa M, Bochner BS, Georas SN, Schleimer RP. Eosinophil
transendothelial migration induced by cytokines. I. Role of endothelial
and eosinophil adhesion molecules in IL-1 beta-induced transendothelial
migration. J Immunol. 1992;149(12):4021-4028.
6. Beck LA, Dalke S, Leiferman KM, et al. Cutaneous injection of RANTES
causes eosinophil recruitment: comparison of nonallergic and allergic
human subjects. J Immunol. 1997;159(6):2962-2972.
7. Stellato C, Collins P, Ponath PD, et al. Production of the novel C-C
chemokine MCP-4 by airway cells and comparison of its biological
activity to other C-C chemokines. The Journal of clinical
investigation. 1997;99(5):926-936.
8. Kikly KK, Bochner BS, Freeman SD, et al. Identification of SAF-2, a
novel siglec expressed on eosinophils, mast cells, and basophils.The Journal of allergy and clinical immunology. 2000;105(6 Pt
1):1093-1100.
9. Dellon ES, Peterson KA, Murray JA, et al. Anti-Siglec-8 Antibody for
Eosinophilic Gastritis and Duodenitis. The New England journal of
medicine. 2020;383(17):1624-1634.
10. Schleimer RP. Immunopathogenesis of Chronic Rhinosinusitis and Nasal
Polyposis. Annu Rev Pathol. 2017;12:331-357.